Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma
by on Friday, August 31st, 2012 | No Comments
Condition: Untreated Stage III Melanoma or Stage IV Melanoma
Interventions: Biological: Ipilimumab; Drug: Carboplatin; Drug: Paclitaxel
Sponsors: Jewish General Hospital; Jewish General Hospital
Not yet recruiting – verified August 2012
Original post: Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma